Banner from TechCrunch Article (Image Credits: Getty Images)Banner from TechCrunch Article (Image Credits: Getty Images)
Back arrow
back

TechCrunch names Illuminant as one of its favorites from YC's S22 Demo Day

In September, Illuminant participated in Y Combinator's Demo Day as part of the S22 batch. TechCrunch selected Illuminant as one of its favorites from hundreds of companies.

Read more here: Our 10 favorite startups from YC’s S22 Demo Day: Part 2

Illuminant overhead equipmentIlluminant overhead equipment

Illuminant allows you to see everything you need to deliver the highest-quality surgical procedures all in one place, in real time.

Our Technology

Similar Articles

Events

Illuminant Displays Technology at COMPUTEX Taipei

As part of Illuminant’s acceptance into the Garage+ Start-up Global Program, founders James Hu and Eldrick Millares traveled to Taipei, Taiwan to showcase Illuminant’s technology to the global community at COMPUTEX 2023.

Blog

Illuminant Demos to Mount Sinai Neurosurgery

Illuminant team demonstrates product to Mount Sinai Department of Neurosurgery ahead of clinical study.

Publications

ASPN Accepts Illuminant Research for 2023 Conference

Research conducted by the Illuminant Clinical Team has been accepted to be presented at the American Society of Pain and Neuroscience (ASPN) 2023 Annual Conference. This research was the first-of-its-kind review on the emerging technologies in interventional percutaneous pain.

Contact Us

Reach out to us to get a closer look at the future of surgical navigation

founders@illuminant.ai
5855 Green Valley Circle
Culver City, CA
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
© 2025 Illuminant. All rights reserved.
Privacy PolicyTerms of Service

The Illuminant Surgical Navigation System is being designed with the intent to improve surgery. All information on this website represents the design goals of Illuminant Surgical and has not been evaluated by the United States Food and Drug Administration (FDA). The product has not been cleared by the FDA and is not for commercial sale in the United States.